Results 11 to 20 of about 38,782 (264)

Effect of alveolar volume on the interpretation of single breath DlCO

open access: bronzeRespiratory Medicine, 1997
Single-breath carbon monoxide diffusing capacity in the whole lung (DLCO) and per unit alveolar volume (DLCO/VA), as expressed in percentage of normal values, gave discordant results when VA of the patients was abnormal. It was hypothesized that normal reference values were inappropriate to interpret data collected in such patients.
Albert Frans   +4 more
semanticscholar   +5 more sources

Pulmonary vascular volume is associated with DLCO and fibrotic score in idiopathic pulmonary fibrosis: an observational study [PDF]

open access: goldBMC Medical Imaging, 2022
Background Idiopathic pulmonary fibrosis (IPF) is a disease that primarily occurs in elderly individuals. However, it is difficult to diagnose and has a complex disease course.
Wen-Jui Wu   +3 more
openalex   +2 more sources

Endoscopic lung volume reduction with endobronchial valves in very low DLCO patients: results from the German Registry – Lungenemphysemregister e.V.

open access: yesERJ Open Research, 2021
Background Endoscopic lung volume reduction (ELVR) with valves has been suggested to be the key strategy for patients with severe emphysema and concomitant low diffusing capacity of the lung for carbon monoxide (DLCO).
Pavlina Lenga   +15 more
doaj   +2 more sources

Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases [PDF]

open access: goldBMC Pulmonary Medicine, 2015
BackgroundDLCO is the product of the CO transfer coefficient (KCO) by the “accessible” alveolar volume (VA). In theory, the same DLCO may result from various combinations of KCO and VA values, each of which reflect different injury sites and mechanisms ...
Jean Pastré   +6 more
openalex   +2 more sources

Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO [PDF]

open access: yesRespiration, 2020
<b><i>Background:</i></b> For selected patients with severe emphysema, bronchoscopic lung volume reduction with endobronchial valves (EBV) is recognized as an additional treatment option. In most trials investigating EBV treatment, patients with a very low diffusing capacity (DLCO) were excluded from participation.
Marlies van Dijk   +5 more
openaire   +4 more sources

Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline

open access: diamondReumatismo, 2016
Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observed in systemic sclerosis (SSc) patients, generally related to the presence of interstitial lung disease (ILD) and/or pulmonary arterial hypertension (PAH).
Michele Colaci   +7 more
openalex   +3 more sources

Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults.

open access: yesPLoS ONE, 2021
Background and objectiveCurrently there is paucity of evidence in the literature in relation to normative values for diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) among Indigenous Australians. Hence, in this study we assessed
Timothy Howarth   +5 more
doaj   +2 more sources

Time-based understanding of DLCO and DLNO

open access: yesRespiratory Physiology & Neurobiology, 2016
Capture of CO and NO by blood requires molecules to travel by diffusion from alveolar gas to haemoglobin molecules inside RBCs and then to react. One can attach to these processes two times, a time for diffusion and a time for reaction. This reaction time is known from chemical kinetics and, therefore, constitutes a unique physical clock.
Bernard Sapoval, Min-Yeong Kang
openaire   +4 more sources

Lower DLco% identifies exercise pulmonary hypertension in patients with parenchymal lung disease referred for dyspnea

open access: yesPulmonary Circulation, 2020
Exercise pulmonary hypertension is an underappreciated form of physical limitation related to early pulmonary vascular disease. A low diffusing capacity of lungs for carbon monoxide (DLco) can be seen in patients with resting pulmonary hypertension as ...
Richard H. Zou   +4 more
doaj   +2 more sources

The prognostic value of DLCO and pulmonary blood flow in patients with pulmonary hypertension [PDF]

open access: yesPulmonary Circulation, 2019
BackgroundCardiac output is a prognostic marker in patients with pulmonary hypertension. Pulmonary blood flow as a surrogate for cardiac output can be measured non‐invasively by inert gas rebreathing. We hypothesized that pulmonary blood flow can predict outcome in patients with pulmonary hypertension.MethodsFrom January 2009 to January 2012, we ...
Stadler, Stefan   +2 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy